• Explore /
  • Poster
  • / Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA CD3 TCB) for the treatment of CEA-expressing solid tumors.

Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA CD3 TCB) for the treatment of CEA-expressing solid tumors.

Abstract Poster

Authors

null

Ignacio Melero

CIMA, CUN, University Navarra, Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Pamplona, Spain

Ignacio Melero , Neil Howard Segal , Jose M. Saro Suarez , Willeke Ros , Maria Martinez Garcia , Emiliano Calvo , Victor Moreno , Santiago Ponce Aix , Aurelien Marabelle , James M. Cleary , Herbert Hurwitz , Joseph Paul Eder , Cancize Jamois , Anton Belousov , Said Bouseida , Federico Sandoval , Marina Bacac , Tapan K. Nayak , Vaios Karanikas , Guillem Argiles

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Other Novel Agents

Citation

J Clin Oncol 35, 2017 (suppl; abstr 2549)

DOI

10.1200/JCO.2017.35.15_suppl.2549

Abstract #

2549

Poster Bd #

41

Abstract Disclosures

Similar Posters

First Author: Omid Hamid

First Author: Jeffrey R. Infante

First Author: Gonzalo Tapia

First Author: Timothy A. Yap